Tumor necrosis factor alpha small interfering RNA decreases herpes simplex virus-induced inflammation in a mouse model.

[1]  P. Rutgeerts,et al.  Remission‐inducing effect of anti‐TNF monoclonal antibody in TNBS colitis: Mechanisms beyond neutralization? , 2007, Inflammatory bowel diseases.

[2]  M. Humbert,et al.  Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists , 2006, Arthritis research & therapy.

[3]  M. Woodle,et al.  Harnessing in vivo siRNA delivery for drug discovery and therapeutic development , 2006, Drug Discovery Today.

[4]  Eun-So Lee,et al.  Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet’s disease , 1996, Archives of Dermatological Research.

[5]  T. Ganesan,et al.  Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. Schiffelers,et al.  Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. , 2005, Arthritis and rheumatism.

[7]  J. Behr,et al.  Lipid‐mediated siRNA delivery down‐regulates exogenous gene expression in the mouse brain at picomolar levels , 2005, The journal of gene medicine.

[8]  B. Williams,et al.  RNA interference and double-stranded-RNA-activated pathways. , 2004, Biochemical Society transactions.

[9]  J. Lieberman,et al.  Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  B. Mahon,et al.  Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo , 2004, Journal of Inflammation.

[11]  C. Edwards.  Drug discovery and development for inflammatory diseases. , 2004, Expert opinion on therapeutic targets.

[12]  J. C. Schmitz,et al.  Small Interfering Double-Stranded RNAs as Therapeutic Molecules to Restore Chemosensitivity to Thymidylate Synthase Inhibitor Compounds , 2004, Cancer Research.

[13]  Raymond M. Schiffelers,et al.  Pharmaceutical Prospects for RNA Interference , 2004, Pharmaceutical Research.

[14]  A. Heiligenhaus,et al.  Topical treatment with antisense oligonucleotides targeting tumor necrosis factor-alpha in herpetic stromal keratitis. , 2003, Investigative ophthalmology & visual science.

[15]  J. Lieberman,et al.  Sustained Small Interfering RNA-Mediated HumanImmunodeficiency Virus Type 1 Inhibition in PrimaryMacrophages , 2003, Journal of Virology.

[16]  B. Li,et al.  Expression profiling reveals off-target gene regulation by RNAi , 2003, Nature Biotechnology.

[17]  T. Tuschl,et al.  Small interfering RNAs: a revolutionary tool for the analysis of gene function and gene therapy. , 2002, Molecular interventions.

[18]  Phillip D Zamore,et al.  Ancient Pathways Programmed by Small RNAs , 2002, Science.

[19]  S. Sohn,et al.  Experimental studies on the antiviral agent famciclovir in Behçet's disease symptoms in ICR mice , 2001, The British journal of dermatology.

[20]  S. Paludan,et al.  Expression of TNF-α by Herpes Simplex Virus-Infected Macrophages Is Regulated by a Dual Mechanism: Transcriptional Regulation by NF-κB and Activating Transcription Factor 2/Jun and Translational Regulation Through the AU-Rich Region of the 3′ Untranslated Region1 , 2001, The Journal of Immunology.

[21]  Eun-So Lee,et al.  Behçet's disease-like symptoms induced by the Herpes simplex virus in ICR mice. , 1998, European journal of dermatology : EJD.

[22]  E. Choi,et al.  Epidemiological and Clinical Features of Behçet’s Disease in Korea , 1997 .

[23]  E. Choi,et al.  Epidemiological and clinical features of Behçet's disease in Korea. , 1997, Yonsei medical journal.

[24]  Chanil Park,et al.  HERPES SIMPLEX VIRUS DETECTION BY POLYMERASE CHAIN REACTION IN INTESTINAL ULCER OF PATIENTES WITH BEHCET'S DISEASE , 1993 .

[25]  J. S. Román,et al.  [Type I herpes virus, HLA phenotype and Behçet disease]. , 1992 .

[26]  K. Ayed,et al.  Natural killer cell activity, interferon‐gamma and antibodies to herpes viruses in patients with Behçet's disease , 1990, Clinical and experimental immunology.

[27]  O. Uhlenbeck,et al.  Synthesis of small RNAs using T7 RNA polymerase. , 1989, Methods in enzymology.

[28]  H. Kim,et al.  Behçet's syndrome in Korea: a look at the clinical picture. , 1988, Yonsei medical journal.

[29]  G. Ehrlich,et al.  Behçet disease (Behçet syndrome). , 1979, Seminars in arthritis and rheumatism.